Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: J Oncol Pract. 2018 Feb 13;14(3):e149–e157. doi: 10.1200/JOP.2017.027730

Figure 3.

Figure 3

Figure 3

Figure 3

Adjusted** average annual costs of cancer for IDN vs. Non-IDN hospitals in A) Initial B) Continuing and C) End of life phase, for cancers with the lowest 5- year survival

*p <0.05

** Adjusted for patient (age, sex, number of Charlson co-morbidities, marital status), hospital (geographic region, number of beds, urban/rural, hospital ownership, surgical volume), and cancer (stage, grade) characteristics